Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.74 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.74 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.621.1 (Mu)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.621.1 (Mu)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.621.1 (Mu)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.621.1 (Mu)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.621.1 (Mu)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.621.1 (Mu)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.621.1 (Mu)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.621.1 (Mu)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BG.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BG.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BG.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BG.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BG.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BG.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BG.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.42.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.42.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.42.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.42.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.42.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.42.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.42.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.42.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.517EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.517EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.517ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.517ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.517EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.517EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.517ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.517ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used